Skip to main content
Premium Trial:

Request an Annual Quote

Donald Halbert, Vishal Wanchoo, Eric Lander, Dorian Rinella, Alain Couder, Jussi Harvela, Jeffrey Duggan, Chris Capelli, David Goldstein

Donald Halbert this week was named executive vice president of research and development for Iconix Pharmaceuticals. Halbert was director of genomics, proteomics, and bioinformatics in the global pharmaceutical research and development group of Abbott Laboratories. Additionally, Halbert directed Abbott's toxicogenomics program and oversaw the scientific advisory committee that directed a collaboration between Abbott and Iconix that was initiated in December 2003. Before joining Abbott, Halbert was an executive with Becton Dickinson.

Vishal Wanchoo has been named president and CEO of GE Healthcare's new healthcare information technologies unit, which will develop clinical information technology connecting hospitals, physicians' offices, and patients. Previously, Wanchoo was vice president and general manager for clinical information technology for GE Healthcare.

Eric Lander will receive this year's Public Understanding of Science and Technology award from the American Association for the Advancement of Science, AAAS said last week. He is the founding director of the Broad Institute of MIT and Harvard and a professor of biology at MIT, a professor of systems biology at Harvard Medical School, and a member of the Whitehead Institute for Biomedical Research. Lander holds a PhD in mathematics from Oxford University and an undergraduate degree in mathematics from Princeton University.

Dorian Rinella was appointed vice president of human resources for Corgentech of South San Francisco. Rinella joined the company from a position as vice president for human resources and facilities for Kosan Biosciences of Hayward, Calif. Rinella previously worked for Bio-Rad.

Alain Couder was named president and chief executive officer of Solid Information Technology, a Cupertino, Calif., company that provides emebedded data management for devices. Couder, a member of the company's board of directors since 1999, previously was chief operating officer for Agilent Technologies. He replaces Jussi Harvela, who will become executive vice president of business development and strategy and remain on the board of directors.

Jeffrey Duggan has been named vice president of analytical operations for Midwest BioResearch, the company said. Duggan was head of bioanalytical laboratory at NeoPharm and previously worked at PerkinElmer. Midwest BioResearch of Evanston, Ill., provides services in bioanalysis, structure identification, and genetic toxicology to pharmaceutical and biotechnology companies.

Chris Capelli, technology transfer director of the University of Pittsburgh, has been named vice president for technology at the MD Anderson Cancer Center of the University of Texas.

David Goldstein has been named director for the new Center for Population Genomics and Pharmacogenetics at Duke University. Goldstein, who will have a joint appointment as professor of molecular genetics and microbiology and biology, is leaving a position as professor of genetics at the Galton Laboratory of the department of biology at University College, London.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.